최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기한국산학기술학회논문지 = Journal of the Korea Academia-Industrial cooperation Society, v.22 no.6, 2021년, pp.314 - 320
오택민 (단국대학교 임상병리학과) , 김가연 (단국대학교 치위생학과) , 이영기 (단국대학교 임상병리학과)
With the increasing age of motherhood in recent years, attributed to late marriages due to social or environmental factors, the Down's syndrome screening test using biochemical markers has become essential for pregnant women. The process of diagnosing Down's syndrome pregnancy in the high-risk group...
E. Jung, "Prenatal screening for Down syndrome", Korean Journal of Obstetrics & Gynecology, Vol.53, No.12, pp.1041-1046, 2010. DOI: https://doi.org/10.5468/kjog.2010.53.12.1041
Y. D. Young, "The evaluation of integrated test as an antenatal screening test for down's syndrome in Korea", Laboratory Medicine Online, Vol.1, No.1, pp.10-18, 2011. DOI: https://doi.org/10.3343/lmo.2011.1.1.10
N. J. Wald, A. Kennard, A. Hackshaw, A. Mcguire, "Antenatal screening for Down's syndrome", Journal of Medical Screening, Vol.4, No.4, 181-246, 1997. DOI: https://doi.org/10.1177%2F096914139700400402
H. S. Cuckle, N. J. Wald, R. Lindenbaum, "Maternal serum alpha-fetoprotein measurement: a screening test for Down syndrome", The Lancet, Vol.323, No.8383, pp.926-929,1984. DOI: https://doi.org/10.1016/S0140-6736(84)92389-4
N. J. Wald, H. S. Cuckle, J. W. Densem, K. Nanchahal, Royston. P., Chard, T, "Maternal serum screening for Down's syndrome in early pregnancy", BMJ Vol.297, No.883-7, pp.1988. DOI: https://doi.org/10.1136/bmj.297.6653.883
Wald, N. J, "Prenatal screening for Down's syndrome using inhibin-A as a serum marker", Prenatal Diagnosis: Published in Affiliation With the International Society for Prenatal Diagnosis, Vol.16, No.2, pp.143-153, 1996. DOI: https://doi.org/10.1002/(SICI)1097-0223(199602)16:2 3.0.CO;2-F
Cuckle, howars, Wald, N. J, Lindenbaum, richardh, "Maternal serum alpha-fetoprotein measurement: a screening test for Down syndrome", The Lancet, Vol.323, No.8383, pp. 926-929, 1984. DOI: https://doi.org/10.1016/S0140-6736(84)92389-4
Van lith, J. M. M, "Second-trimester maternal serum immunoreactive inhibin as a marker for fetal Down's syndrome", Prenatal diagnosis, Vol.12, No.10, pp.801-806, 1992. DOI: https://doi.org/10.1002/pd.1970121005
Wald, N. J., Rish, Simon., Hackshaw, K. Allan, "Combining nuchal translucency and serum markers in prenatal screening for Down syndrome in twin pregnancies", Prenatal diagnosis, Vol.23, No.7, pp.588-592, 2003. DOI: https://doi.org/10.1002/pd.627
Groome, P. nigel, evans, W. Lee, "Does measurement of inhibin have a clinical role", Annals of clinical biochemistry, Vol.37, No.4, pp.419-431, 2000. DOI: https://doi.org/10.1177%2F000456320003700401
Hussamy DJ, Herrera CL, Twickler DM, Mcintire DD, Dashe JS. "Number of Risk Factors in Down Syndrome Pregnancies" Am J Perinatol. Vol 36, pp.79-85, 2019 DOI: https://doi.org/10.1055/s-0038-1666974
R. Bindra, Heath, V., Liao, A, Spencer, K., Nicolaides, KH, "One-stop clinic for assessment of risk for trisomy 21 at 11-14 weeks: a prospective study of 15,030 pregnancies", Ultrasound Obstet Gynecol, Vol.20, pp.219-25, 2002. DOI: https://doi.org/10.1046/j.1469-0705.2002.00808.x
Brizot, M. L, "Maternal serum hCG and fetal nuchal translucency thickness for the prediction of fetal trisomies in the first trimester of pregnancy", BJOG: An International Journal of Obstetrics & Gynaecology, Vol.102, No.2, pp.127-132, 1995. DOI: https://doi.org/10.1111/j.1471-0528.1995.tb09065.x
Alldred SK, Takwoingi Y, Guo B, Pennant M, Deeks JJ, Neilson JP, Alfirevic Z. First trimester ultrasound tests alone or in combination with first trimester serum tests for Down's syndrome screening. "Cochrane Database of Systematic Reviews 2017" Issue 3. 2021. DOI: https://doi.org/10.1002/14651858.CD012600
Wald, N. J. "First and second trimester antenatal screening for Down's syndrome: the results of the Serum, Urine and Ultrasound Screening Study (SURUSS)", Journal of medical screening, Vol.10, No.2, pp.56-104, 2003. DOI: https://doi.org/10.1177%2F096914130301000202
Wapner, J. ronald, "First trimester screening: the BUN study. In: Seminars in perinatology", WB Saunders, p, pp.236-239, 2005. DOI: https://doi.org/10.1053/j.semperi.2005.05.013
C. Y. Choi, et al, "DSCR 1-mediated TET 1 splicing regulates miR-124 expression to control adult hippocampal neurogenesis", The EMBO journal, Vol.38, No.14 pp.e101293, 2019 DOI https://doi.org/10.15252/embj.2018101293
Hook, ernest B, "Rates of chromosome abnormalities at different maternal ages", Obstetrics and gynecology, Vol.8, No.3 pp.282-285, 1981.
H. S. Cuckle, Wald, N. J, THOMPSON, S. G, "Estimating a woman's risk of having a pregnancy associated with Down's syndrome using her age and serum alpha-fetoprotein level", BJOG: An International Journal of Obstetrics & Gynaecology, Vol.94, No.5 pp.387-402, 1987. DOI: https://doi.org/10.1111/j.1471-0528.1987.tb03115.x
Saller, N. devereux, Canick, A. jacob, "Maternal serum screening for fetal Down syndrome: clinical aspects", Clinical obstetrics and gynecology, 39.4: 783-792, 1996.
N. J. Wald, H. C. Watt, Hackshaw, A. K, "Integrated screening for Down's syndrome based on tests performed during the first and second trimesters", New England Journal of Medicine, Vol.341, NO.7, pp.461-467, 1999. DOI: https://doi.org/10.1056/NEJM199908123410701
Malone, D. fergal, "First-trimester sonographic screening for Down syndrome", Obstetrics & Gynecology, Vol.102, No.5 pp.1066-1079, 2003. DOI: https://doi.org/10.1016/j.obstetgynecol.2003.08.004
Pandya, P. pranav , "Screening for fetal trisomies by maternal age and fetal nuchal translucency thickness at 10 to 14 weeks of gestation", BJOG: An International Journal of Obstetrics & Gynaecology, Vol.102 No.12, pp.957-962, 1995. DOI: https://doi.org/10.1111/j.1471-0528.1995.tb10902.x
D. M. Strah, P. Maja, Gersak, Ksenija, "Risk assessment of trisomy 21 by maternal age and fetal nuchal translucency thickness in 7096 unselected pregnancies in Slovenia", Journal of perinatal medicine, Vol.36, No.2, pp.145-150, 2008.
ACOG educational bulletin. Adult manifestation of childhood sexual abuse. 2000. number 259, Clinical management guidelines for obstetrician-gynecologists. Int J Gynaecol Obstet, Vol.74, pp.311-20, 2001.
T. S. martin, "Responding to parental concerns after a prenatal diagnosis of trisomy 21", Journal of developmental and behavioral pediatrics, Vol.18, No.1, pp.42-46, 1997. DOI: https://doi.org/10.1515/JPM.2008.015
Rose, Nancy C. MD, Kaimal, Anjali J. MD, MAS, Dugoff, Lorraine MD, Norton, Mary E. MD. "Committee on Practice Bulletins-Obstetrics Committee on Genetics Society for Maternal-Fetal Medicine Screening for Fetal Chromosomal Abnormalitie"American College of Obstetricians and Gynecologists. Vol.136, pp48-69, 2020. DOI: https://doi.org/10.1097/AOG.0000000000004084
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
Free Access. 출판사/학술단체 등이 허락한 무료 공개 사이트를 통해 자유로운 이용이 가능한 논문
※ AI-Helper는 부적절한 답변을 할 수 있습니다.